We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
+8.03%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$21.4B
AUM Growth
+$2.26B
(+12%)
Cap. Flow
+$869M
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
16.69%
Holding
1,355
New
99
Increased
787
Reduced
415
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$65.7M |
| 2 |
Moderna
MRNA
|
+$40M |
| 3 |
Microsoft
MSFT
|
+$38.7M |
| 4 |
NextEra Energy
NEE
|
+$36.2M |
| 5 |
Jack Henry & Associates
JKHY
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$41.7M |
| 2 |
ON Semiconductor
ON
|
+$37.5M |
| 3 |
HCA Healthcare
HCA
|
+$28.9M |
| 4 |
Cummins
CMI
|
+$27.8M |
| 5 |
Chevron
CVX
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20% |
| 2 | Financials | 14.17% |
| 3 | Healthcare | 13.11% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Kinross Gold
KGC
$28.1B
| $374K | ﹤0.01% |
58,946
+5,860
| +11% | +$43.5K |
|
|
JBGS
1252
JBG SMITH
JBGS
$839M
| $365K | ﹤0.01% |
11,594
+112
| +1% | +$3.65K |
|
1253
SK Telecom
SKM
$11.9B
| $363K | ﹤0.01% |
+7,013
| New | +$357K |
|
1254
CareTrust REIT
CTRE
$10.2B
| $359K | ﹤0.01% |
15,453
+938
| +6% | +$22.1K |
|
1255
Latham Group
SWIM
$672M
| $352K | ﹤0.01% |
+11,012
| New | +$322K |
|
1256
iShares Gold Trust
IAU
$62.7B
| $351K | ﹤0.01% |
10,420
-7,907
| -43% | -$273K |
|
1257
ZipRecruiter
ZIP
$365M
| $351K | ﹤0.01% |
+14,055
| New | +$318K |
|
|
AVYA
1258
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $349K | ﹤0.01% |
12,960
-17,395
| -57% | -$489K |
|
|
VG
1259
DELISTED
Vonage Holdings Corporation
VG
| $349K | ﹤0.01% |
24,231
+2,683
| +12% | +$36.7K |
|
|
TEF
1260
DELISTED
Telefonica
TEF
| $348K | ﹤0.01% |
+79,277
| New | +$343K |
|
1261
O-I Glass
OI
$1.46B
| $347K | ﹤0.01% |
21,279
+3,650
| +21% | +$61.8K |
|
|
CVET
1262
DELISTED
Covetrus, Inc. Common Stock
CVET
| $346K | ﹤0.01% |
12,825
-924
| -7% | -$25.9K |
|
1263
Banco de Chile
BCH
$20.8B
| $342K | ﹤0.01% |
17,320
-73
| -0.4% | -$1.57K |
|
|
ROIC
1264
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $341K | ﹤0.01% |
19,318
+3,506
| +22% | +$61.6K |
|
1265
Cytokinetics
CYTK
$10.8B
| $339K | ﹤0.01% |
17,139
-772
| -4% | -$18.1K |
|
1266
Braskem
BAK
$964M
| $337K | ﹤0.01% |
14,115
| – | – |
|
|
TPH
1267
DELISTED
Tri Pointe Homes
TPH
| $337K | ﹤0.01% |
15,721
+3,639
| +30% | +$83.3K |
|
1268
Teck Resources
TECK
$28.5B
| $332K | ﹤0.01% |
14,404
+2,121
| +17% | +$48.2K |
|
1269
Benchmark Electronics
BHE
$2.7B
| $330K | ﹤0.01% |
11,589
-695
| -6% | -$21K |
|
1270
Box
BOX
$4.38B
| $327K | ﹤0.01% |
+12,789
| New | +$298K |
|
|
BDN
1271
Brandywine Realty Trust
BDN
$521M
| $324K | ﹤0.01% |
23,645
+2,428
| +11% | +$33.5K |
|
|
TVRD
1272
Tvardi Therapeutics
TVRD
$23M
| $324K | ﹤0.01% |
631
+214
| +51% | +$136K |
|
1273
Peapack-Gladstone Financial
PGC
$846M
| $316K | ﹤0.01% |
10,166
-195
| -2% | -$6.29K |
|
|
LFC
1274
DELISTED
China Life Insurance Company Ltd.
LFC
| $316K | ﹤0.01% |
31,713
-3,772
| -11% | -$38.6K |
|
1275
Valley National Bancorp
VLY
$8.03B
| $306K | ﹤0.01% |
22,804
+3,735
| +20% | +$52.2K |
|
Similar funds
BC
Natixis Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Natixis Advisors held 1,355 positions worth $21.4B, up 12% from $19.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Natixis Advisors deployed $869M of net new capital in Q2 2021, opening 99 new positions and adding to 787 existing holdings. Its largest new stake was Moderna: 223,547 shares worth $52.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Canadian National Railway, an estimated $41.7M trimmed.
- Natixis Advisors's largest Q2 2021 buy was Moderna: 223,547 shares worth $52.5M.
- Natixis Advisors added most to Apple in Q2 2021, an estimated $65.7M increase.
- Natixis Advisors's biggest Q2 2021 reduction was Canadian National Railway, cutting an estimated $41.7M.
- Natixis Advisors fully exited Corelogic, Inc. in Q2 2021, selling an estimated $16.7M.
- Natixis Advisors's ten largest holdings make up 17% of its $21.4B portfolio in Q2 2021.
- Natixis Advisors opened 99 new positions and closed 50 in Q2 2021.
- Natixis Advisors's portfolio value rose 12% quarter-over-quarter to $21.4B.
Based on Natixis Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.